Phase 2, randomized, 3-arm study of abiraterone acetate and prednisone (AAP), AAP plus degarelix (AAP+D), and degarelix (D) alone for patients (pts) with biochemically-recurrent prostate cancer (PC…

@SoaresAndrey @BertrandTOMBAL @neerajaiims @Silke_Gillessen @ChrisSweens1 Thank you, thank you. Should have been thinking more widely. Similar for bicalutamide? https://t.co/DcJAeb2mMZ Abiraterone? Smaller studies but is there a longer RCT in progress? …